NIA Study Confirms Protandim Nrf2 Synergizer Extends Life. The New Study from the National Institute of Aging Interventions Testing Program (NIA ITP) Shows Protandim Significantly Extends Lifespan in Male Mice.
In a press release issued in SALT LAKE CITY, Aug. 02, 2016, LifeVantage formally
READ MORE
Hate Diabetes? Nrf2 Activation Therapy Provides Hope For Diabetic Nephropathy
For those with diabetes, there is new hope for those suffering from diabetes and diabetes complications with Nrf2 activation.
Diabetes is the leading cause of end-stage renal disease (chronic kidney disease) and top diabetes organizations and Diabetes Research institutions like the American
READ MORE